PointState Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

PointState Capital’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-24,834	Closed	-$566K	–	153
2015 Q2	$566K	Buy	+24,834	New	+$495K	0.01%	143
2014 Q1	–	Sell	-350,000	Closed	-$6.19M	–	164
2013 Q4	$6.19M	Buy	+350,000	New	+$5.88M	0.08%	108

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

PointState Capital's MNTA Position: Q3 2015 in Review

PointState Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2015, closing a stake of 24,834 shares — an estimated $566K sold.

PointState Capital first reported a position in MNTA in Q4 2013 and held it in 2 quarters. The position peaked at $6.19M in Q4 2013. 156 funds tracked by Wall St. Rank hold MNTA as of Q3 2015.

PointState Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
PointState Capital sold 24,834 Momenta Pharmaceuticals, Inc. shares in Q3 2015, an estimated $566K.
PointState Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 2 quarters.
PointState Capital's Momenta Pharmaceuticals, Inc. position peaked at $6.19M in Q4 2013.
156 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2015.

Based on PointState Capital's 13F filing for Q3 2015, filed 16 Nov 2015.